Brian, I have never been able to figure out the strategy Morningstar uses for their "Featured funds" It seems that as soon as I spot one the link disappears.
In this case, I should have looked more closely. The link, which took one to the analyst's research, did have the Premium Member symbol in front of it, which means that many people who visit this forum would not have access. I will,however, put a link to the research at the end of this message.
Here are a few quotations that might be helpful.
". . .actively managed sector funds
need low expenses and strong management to outperform. This fund is one of the few that have both. . . .Given low expenses and strong management, the fund's standout returns
are no surprise. Since the start of 2000, the fund has beaten most of
its category peers, and it looks strong next to its passively managed
rivals."
"Strategy: Kris Jenner emphasizes smaller-cap
pharmaceutical and biotech stocks, which he thinks have the brightest long-term
growth prospects in the health-care sector. Recognizing that such names are
often quite volatile, Jenner has also given the fund considerable exposure to
big-cap drugmakers and health-care service companies. Even so, with a hefty
biotech stake and a market cap far below the category average, the fund is more
adventuresome than most diversified health-care offerings."
Here is the link: TRP Health Sciences Fund
Hetty, I"m still buzzing around, doing my best to give my progeny a hard time. Housekeeping is a disaster for now, because a beautiful Spring means that it is much more fun to work outside than to worry about dust inside.
Lorna
